Searched for
PHARMA FUNDS VALUATION SAFE OR EXPENSIVE
Pharma mutual funds top return charts across horizons. Should investors chase the rally or stay cautious?Pharma mutual funds are leading returns in CY2026, driven by strong earnings, defensive demand, and US export growth. Despite recent outper...- MFs push back on Zepto valuation; PEs take AI betsHappy Monday! Zepto's IPO pricing expectation has run into resistance from top mutual funds. This and more in today's ETtech Morning Dispat...
- ETMarkets AIF Talk | Next-generation entrepreneurs will create India's biggest wealth opportunities: Hiren VedIndia's next wealth creation wave will emerge from new entrepreneurs in strategic sectors. These founders leverage advanced technologies to...
- Looking for better SIP returns? This mutual fund category has outperformedSystematic investment plans build wealth, but returns differ across mutual fund types. Sectoral funds, particularly pharma and healthcare, ...
- Top funds demand deeper valuation cut for Zepto IPOThe asset managers, among the biggest investors in recent IPOs, have told Bengaluru-based Zepto's representatives in recent discussions tha...
- PhonePe FY26 losses surge 62% to Rs 2,792 crore, revenue up 11%Walmart-owned fintech company PhonePe has posted an 11% increase in its operating revenue for fiscal 2026 at Rs 7,920 crore. Its net loss, ...
- US-China AI race is heating up, but these 10 professions are still too expensive for robots to replace - is your job safe?Jobs safe from AI: Americans perceive China leading in artificial intelligence development currently. However, automating many common jobs ...
- 360 ONE's Mayur Patel bets on smallcaps, says midcaps look somewhat expensive360 ONE Asset's Mayur Patel believes smallcaps currently offer better risk-reward than expensive midcaps. The fund has increased smallcap e...
- Elon Musk's Boring Company seeks funding at $20 billion valuation: WSJThe Boring Company was valued at $5.7 billion in 2022 after a $675-million fundraising exercise. Musk, whose business interests include Te...
- Dixon Technologies, Paras Defence among 14 new stocks added by this one-year topper mutual fund in JuneTRUSTMF Small Cap Fund, the best-performing equity mutual fund over the past one year with a 21.98% return, added Dixon Technologies (India...
- All bad news is priced in, but don't call it a bull market yet: SAMCO MF CEO Viraj GandhiLargecaps offer better safety as valuations are below historical averages. Private banks and cement sectors show clear earnings visibility ...
- Cipla Q1 Results: Cons profit drops 39% YoY to Rs 789 crore; revenue rises marginallyCipla Q1 Results: Pharma major Cipla reported a 39% year-on-year decline in Q1FY27 consolidated net profit to Rs 789 crore, mainly due to a...
- Oil at $90-100 will impact macros and the market: Sunil Koul, Goldman SachsGlobal investors show increased interest in India's equity markets recently. Corporate earnings and economic performance have remained quit...
- Best balanced advantage funds or dynamic asset allocation funds to invest in July 2026Balanced advantage funds dynamically manage equity exposure based on market conditions. These hybrid schemes invest in stocks, debt, and ar...
- Temasek doubles down on India; sees long-term opportunities in family businessesTemasek International sees family businesses opening to investors as a major market shift. Generational transitions create attractive long-...
- MedPlus Health shares tumble 16% after Q1 profit falls 21% YoY. Should you buy, sell or hold?MedPlus Health Services shares tumbled after the company reported a weaker-than-expected Q1FY27. Despite healthy 21.9% revenue growth to ₹1...
- FIIs just pumped $3 billion into Indian stocks as brutal selloff ends. Here's what they are buyingForeign investors have injected nearly $3 billion into Indian equities recently. Financial services and consumer services attracted signifi...
- SBI Funds Management gets 2 fresh buy calls. Why Equirus and Emkay see up to 31% upsideSBI Funds Management received bullish brokerage coverage from Equirus Securities and Emkay Global, with target prices implying up to 31% up...
- Natco Pharma shares surge 5% after US FDA's tentative nod Olaparib tabletsNatco Pharma shares rose sharply on Monday after the U.S. FDA granted tentative approval for its generic Olaparib tablets, a bioequivalent ...
- Databricks secures funding round at $188 billion valuationDatabricks said on Thursday it has signed a term sheet for a strategic funding round that values the data analytics software firm at $188 b...
Load More
